Literature DB >> 21869711

Magnetic resonance angiography in extracranial giant cell arteritis.

Marcel Koenigkam-Santos1, Puneet Sharma, Bobby Kalb, John N Oshinski, Cornelia M Weyand, Jörg J Goronzy, Diego R Martin.   

Abstract

BACKGROUND: Noninvasive diagnosis of giant cell arteritis (GCA) remains challenging, particularly with regard to evaluation of extracranial arterial disease.
OBJECTIVES: The objective of the study was to retrospectively review extracranial involvement in patients with GCA and/or polymyalgia rheumatica (PMR), evaluated with magnetic resonance imaging (MRI), especially 3-dimensional contrast-enhanced magnetic resonance angiography images of the aortic arch and its branches.
METHODS: Clinical information, biopsy status, and MRI examinations of 28 patients with GCA/PMR were reviewed. Patient images were mixed randomly with 20 normal control images and were independently reviewed by 2 radiologists. Interobserver agreement for detection of arterial stenosis was determined by the k coefficient.
RESULTS: Both readers described vascular alterations in keeping with extracranial GCA in 19 of 28 patients (67%) with good interobserver agreement (k = 0.73) and with even higher agreement on diagnosing nonocclusive versus occlusive disease (k = 1.00). The most common lesions were bilateral axillary stenosis or obstructions, observed by both readers in 8 patients (28%). Among the 19 patients with magnetic resonance angiography lesions in the subclavian/axillary arteries, 12 (75%) had biopsy-proven GCA, but only 5 (41%) of these patients had clinical features of large artery disease.
CONCLUSIONS: In our series review, MRI could provide accurate information on involvement of the aortic arch and its branches in extracranial GCA, depicting different degrees of stenosis. Our analysis also illustrates that occult large artery vasculitis should be considered in patients without biopsy-proven GCA, patients with classic GCA but without clinical signs of large artery disease, and in patients initially diagnosed as having PMR.

Entities:  

Mesh:

Year:  2011        PMID: 21869711      PMCID: PMC4271838          DOI: 10.1097/RHU.0b013e31822acec6

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  26 in total

1.  Limited value of temporal artery ultrasonography examinations for diagnosis of giant cell arteritis: analysis of 77 subjects.

Authors:  Carla Maldini; Caroline Dépinay-Dhellemmes; Thi T S Tra; Michel Chauveau; Yannick Allanore; Laure Gossec; Geneviève Terrasse; Loïc Guillevin; Joël Coste; Alfred Mahr
Journal:  J Rheumatol       Date:  2010-09-01       Impact factor: 4.666

2.  3-T MRI reveals cranial and thoracic inflammatory changes in giant cell arteritis.

Authors:  T A Bley; M Uhl; N Venhoff; J Thoden; M Langer; M Markl
Journal:  Clin Rheumatol       Date:  2006-04-25       Impact factor: 2.980

Review 3.  [MRI in giant cell (temporal) arteritis].

Authors:  T A Bley; M Uhl; M Markl; A Frydrychowicz; M Langer
Journal:  Rofo       Date:  2007-07

4.  Diagnostic value of T2-weighted imaging for the detection of superficial cranial artery inflammation in giant cell arteritis.

Authors:  Julia Geiger; Thorsten Bley; Markus Uhl; Alex Frydrychowicz; Mathias Langer; Michael Markl
Journal:  J Magn Reson Imaging       Date:  2010-02       Impact factor: 4.813

5.  Giant cell arteritis associated with lesion of the internal carotid artery: assessment of response to steroid therapy by magnetic resonance angiography.

Authors:  Hidehiro Takekawa; Yasuhisa Daimon; Ryotaro Takashima; Saiko Aiba; Hideaki Tanaka; Koichi Hirata
Journal:  Intern Med       Date:  2008-07-01       Impact factor: 1.271

Review 6.  Imaging findings in extracranial (giant cell) temporal arteritis.

Authors:  A W Stanson
Journal:  Clin Exp Rheumatol       Date:  2000 Jul-Aug       Impact factor: 4.473

7.  Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions.

Authors:  Markus Aschwanden; Friederike Kesten; Martin Stern; Christoph Thalhammer; Ulrich A Walker; Alan Tyndall; Kurt A Jaeger; Christoph Hess; Thomas Daikeler
Journal:  Ann Rheum Dis       Date:  2010-05-24       Impact factor: 19.103

8.  [18F-FDG PET in the diagnosis of large vessel vasculitis].

Authors:  Z Rehák; Z Fojtík; J Stanícek; K Bolcák; L Frysáková
Journal:  Vnitr Lek       Date:  2006-11

9.  Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study.

Authors:  W A Schmidt; A Natusch; D E Möller; K Vorpahl; E Gromnica-Ihle
Journal:  Clin Exp Rheumatol       Date:  2002 May-Jun       Impact factor: 4.473

10.  [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis.

Authors:  J C Henes; M Müller; J Krieger; B Balletshofer; A C Pfannenberg; L Kanz; I Kötter
Journal:  Clin Exp Rheumatol       Date:  2008 May-Jun       Impact factor: 4.473

View more
  8 in total

1.  Bilateral axillary arterial obstruction.

Authors:  Beatrice van der Matten; Adrienne Anne Marie Zandbergen; Adriaan Dees
Journal:  BMJ Case Rep       Date:  2014-01-22

Review 2.  Imaging in Giant Cell Arteritis.

Authors:  Asad Khan; Bhaskar Dasgupta
Journal:  Curr Rheumatol Rep       Date:  2015-08       Impact factor: 4.592

3.  Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016.

Authors:  Antoine G Sreih; Fatma Alibaz-Oner; Tanaz A Kermani; Sibel Z Aydin; Peter F Cronholm; Trocon Davis; Ebony Easley; Ahmet Gul; Alfred Mahr; Carol A McAlear; Nataliya Milman; Joanna C Robson; Gunnar Tomasson; Haner Direskeneli; Peter A Merkel
Journal:  J Rheumatol       Date:  2017-09-01       Impact factor: 4.666

Review 4.  Non-invasive imaging of vascular inflammation.

Authors:  Enrico Ammirati; Francesco Moroni; Patrizia Pedrotti; Isabella Scotti; Marco Magnoni; Enrica P Bozzolo; Ornella E Rimoldi; Paolo G Camici
Journal:  Front Immunol       Date:  2014-08-18       Impact factor: 7.561

5.  Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT.

Authors:  K D F Lensen; E F I Comans; A E Voskuyl; C J van der Laken; E Brouwer; A T Zwijnenburg; L M Pereira Arias-Bouda; A W J M Glaudemans; R H J A Slart; Y M Smulders
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

Review 6.  Clinical value of whole-body PET/CT in patients with active rheumatic diseases.

Authors:  Hiroyuki Yamashita; Kazuo Kubota; Akio Mimori
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

Review 7.  CMR in inflammatory vasculitis.

Authors:  Subha V Raman; Ashish Aneja; Wael N Jarjour
Journal:  J Cardiovasc Magn Reson       Date:  2012-11-30       Impact factor: 5.364

Review 8.  Imaging of Non-atherosclerotic Vasculopathies.

Authors:  Amit Agarwal; Girish Bathla; Sangam Kanekar
Journal:  J Clin Imaging Sci       Date:  2020-10-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.